Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | MMP2 | P08253 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.48 |
| ▸ | NAAA | Q02083 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MMP1 | P03956 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | DRD2 | P14416 | 1/20 | 0.45 |
| ▸ | DRD3 | P35462 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17580836 | 0.94 | NAAA (0.54) | TSHRHTTSMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL30545066 | 0.92 | EPHX1 (0.57) | SMN1; SMN2KDM4EALDH1A1EPHX1NAAA | |
| SCHEMBL17580570 | 0.87 | HTT (0.51) | TSHRHTTSMN1; SMN2MMP2KDM4E | |
| SCHEMBL17705861 | 0.86 | POLB (0.47) | TSHRHTTMMP2KDM4EALDH1A1 | |
| SCHEMBL6495739 | 0.80 | HTT (0.58) | TSHRHTTSMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL14344290 | 0.80 | HTT (0.49) | TSHRHTTSMN1; SMN2MMP2KDM4E | |
| SCHEMBL8766702 | 0.79 | HTT (0.51) | TSHRHTTSMN1; SMN2MMP2KDM4E | |
| SCHEMBL159955 | 0.76 | HTT (0.49) | TSHRHTTSMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL13528392 | 0.76 | HTT (0.45) | TSHRHTTSMN1; SMN2MMP2KDM4E | |
| SCHEMBL10245160 | 0.76 | TSHR (0.49) | TSHRHTTSMN1; SMN2MMP2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3191460-B1 | PROCESS FOR THE PREPARATION OF TRIAZINE CARBAMATES | ALLNEX NETHERLANDS BV (NL) | 2020-01-29 | — | — | EP | disclosed |
| US-10071972-B2 | Process for the preparation of triazine carbamates | ALLNEX NETHERLANDS B.V. (NL) | 2018-09-11 | — | — | US | disclosed |
| US-20170233353-A1 | PROCESS FOR THE PREPARATION OF TRIAZINE CARBAMATES | ALLNEX IP S.À.R.L. (LU) | 2017-08-17 | — | — | US | disclosed |
| EP-3191460-A1 | PROCESS FOR THE PREPARATION OF TRIAZINE CARBAMATES | Allnex IP S.à.r.l. (LU) | 2017-07-19 | — | — | EP | disclosed |
| WO-2016037973-A1 | PROCESS FOR THE PREPARATION OF TRIAZINE CARBAMATES | ALLNEX IP S.À.R.L. (LU) | 2016-03-17 | — | — | WO | disclosed |
| EP-2995613-A1 | Process for the preparation of triazine carbamates | Allnex IP S.à.r.l. (LU) | 2016-03-16 | — | — | EP | disclosed |
| WO-2015028513-A1 | ANTIMICROBIAL COATINGS | BASF SE (DE) | 2015-03-05 | — | — | WO | disclosed |
| US-8742003-B2 | Silylated amino resins | BASF SE (DE) | 2014-06-03 | — | — | US | disclosed |
| US-20140066552-A1 | SILYLATED AMINO RESINS | BASF SE (DE) | 2014-03-06 | — | — | US | disclosed |
| US-8657947-B2 | Silylated amino resins | BASF SE (DE) | 2014-02-25 | — | — | US | disclosed |
| US-20070196668-A1 | Method For Producing 1,3,5-Triazine Carbamates And Ureas | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-23 | — | — | US | disclosed |
| EP-1737834-A1 | METHOD FOR PRODUCING 1,3,5-TRIAZINE CARBAMATES AND UREAS | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-03 | — | — | EP | disclosed |
| WO-2005100328-A1 | METHOD FOR PRODUCING 1,3,5-TRIAZINE CARBAMATES AND UREAS | BASF AKTIENGESELLSCHAFT (DE) | 2005-10-27 | — | — | WO | disclosed |
| EP-0758325-B1 | A PROCESS FOR PREPARING ISOCYANATE AND ISOCYANATE-BASED DERIVATIVES OF CERTAIN AMINO-1,3,5-TRIAZINES BY DIRECT PHOSGENATION | CYTEC TECH CORP (US) | 2003-07-02 | — | — | EP | disclosed |
| US-6448398-B1 | FREE AND BLOCKED ISOCYANATE AND CARBAMATE FUNCTIONALIZED 1,3,5-TRIAZINES | CYTEC TECHNOLOGY CORP. | 2002-09-10 | — | — | US | disclosed |
| EP-0787129-A1 | PROCESS FOR PREPARING ACID AMIDES | CYTEC TECHNOLOGY CORP. (US) | 1997-08-06 | — | — | EP | disclosed |
| EP-0758325-A1 | A PROCESS FOR PREPARING ISOCYANATE AND ISOCYANATE-BASED DERIVATIVES OF CERTAIN AMINO-1,3,5-TRIAZINES BY DIRECT PHOSGENATION | CYTEC TECHNOLOGY CORP. (US) | 1997-02-19 | — | — | EP | disclosed |
| US-5556971-A | Process for preparing isocyanate and isocyanate-based derivatives of certain amino-1,3,5-triazines by direct phosgenation | CYTEC TECHNOLOGY CORP. (US) | 1996-09-17 | — | — | US | disclosed |
| WO-1996011915-A1 | PROCESS FOR PREPARING ACID AMIDES | CYTEC TECHNOLOGY CORP. (US) | 1996-04-25 | — | — | WO | disclosed |
| WO-1995030663-A1 | A PROCESS FOR PREPARING ISOCYANATE AND ISOCYANATE-BASED DERIVATIVES OF CERTAIN AMINO-1,3,5-TRIAZINES BY DIRECT PHOSGENATION | CYTEC TECHNOLOGY CORP. (US) | 1995-11-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070196668-A1 | Method For Producing 1,3,5-Triazine Carbamates And Ureas | USP5, UMPS, UTS2R | TSHR 783/4885HTT 452/4885SMN1; SMN2 4236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.